Mannitol-Infusionslösung 20

Mannitol, the active ingredient in Mannitol-Infusionslösung 20, is an osmotic diuretic presented as an intravenous solution for intravenous use. It is employed to reduce intracranial pressure, lower intra‑ocular pressure, and promote diuresis in acute renal failure, and is supplied in a standard concentration suitable for infusion therapy.

GNH USA supplies Mannitol-Infusionslösung 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, and clinics worldwide.

Mannitol is used in clinical situations that require osmotic reduction of fluid pressure.

- Intracranial hypertension: reduces elevated intracranial pressure. - Elevated intra‑ocular pressure: lowers pressure within the eye. - Acute renal failure with oliguria: promotes diuresis to aid renal clearance.

Mannitol may be associated with a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea: feeling of unease often accompanied by stomach upset. - Vomiting: expulsion of stomach contents. - Thirst: increased desire to drink fluids. - Electrolyte imbalance: mild changes in sodium or potassium levels. - Transient hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects: - Acute renal failure worsening: severe decline in kidney function. - Pulmonary edema: fluid accumulation in the lungs. - Severe electrolyte disturbances: marked hyponatremia or hyperkalemia. - Anaphylactic reaction: rapid onset of allergic symptoms. - Hemolysis: destruction of red blood cells. - Seizures: neurological events due to rapid osmolar shifts.

Mannitol administration requires careful clinical monitoring.

- Assess renal function: evaluate baseline creatinine and glomerular filtration rate. - Monitor serum electrolytes: check sodium, potassium, and osmolality regularly. - Monitor fluid balance: record input and output to avoid overload. - Avoid in severe dehydration: ensure adequate intravascular volume before infusion. - Use cautiously in heart failure: consider risk of fluid shifts. - Adjust dosing in elderly patients: start with lower infusion rates. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Mannitol can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Loop diuretics: may cause excessive diuresis and electrolyte loss. - Insulin: osmotic shifts can potentiate hypoglycemia. - Lithium: increased risk of lithium toxicity. - ACE inhibitors: enhanced renal effects leading to dysfunction. - Antifungal agents (e.g., amphotericin B): additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood pressure lowering. - NSAIDs: may impair renal perfusion. - Anticonvulsants: altered fluid balance may affect drug levels. - Corticosteroids: potential for compounded electrolyte disturbances.